AstraZeneca and Johnson & Johnson have restarted their late-stage trials after finding that serious illnesses in a few volunteers appeared not to be related to the vaccines. ...
Related News
US arm of AstraZeneca's coronavirus vaccine trial could resume this WEEK after it was paused ...
AstraZeneca Plc plans to resume the US arm of its coronavirus vaccine trial as early as this week after the US Food and Drug Administration (FDA) completed its review of...
The Daily Mail 2020-10-20AstraZeneca close to restarting Covid-19 vaccine trial in U.S.
Vaccine Race AstraZeneca close to restarting Covid-19 vaccine trial in U.S. If the U.S. trial restarts, AstraZeneca will look to finish enrolling 30,000 participants. A...
Politico 2020-10-21US set to resume Oxford University Covid-19 vaccine trials after illness review
...
The Daily Telegraph 2020-10-21AstraZeneca, Johnson&Johnson to resume Covid-19 vaccine trials in US
Drugmakers AstraZeneca and Johnson & Johnson both said Friday they are set to resume their paused coronavirus vaccine trials in the United States after health scares....
Henry Herald
2020-10-24
US trial of AstraZeneca Covid-19 vaccine may resume this week
AstraZeneca Plc’s Covid-19 vaccine trial in the US is expected to resume as early as this week after the US Food and Drug Administration completed its review of a serious...
Business Line 2020-10-21Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its...
The Times of India 2020-10-21FDA will let US trials of AstraZeneca and Oxford's coronavirus vaccine resume - as reports ...
US regulators said on Wednesday that AstraZeneca can resume the US arm of its trial of Oxford University's coronavirus vaccine, according to documents obtained by the Wall...
The Daily Mail 2020-10-23